BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23750511)

  • 21. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.
    Billette de Villemeur T; Gelot A; Deslys JP; Dormont D; Duyckaerts C; Jardin L; Denni J; Robain O
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):111-7. PubMed ID: 8072642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft.
    Yamada S; Aiba T; Endo Y; Hara M; Kitamoto T; Tateishi J
    Neurosurgery; 1994 Apr; 34(4):740-3; discussion 743-4. PubMed ID: 8008177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variant Creutzfeldt Jakob Disease.
    Painter MJ
    J Infect; 2000 Sep; 41(2):117-24. PubMed ID: 11023754
    [No Abstract]   [Full Text] [Related]  

  • 24. Electronmicroscopic detection of prion-protein-positive fibres in brain from iatrogenic Creutzfeldt-Jakob disease.
    Billete de Villemeur T; Fournier JG; Robain O; Escaig-Haye F; Brown P
    Lancet; 1995 Apr; 345(8953):861-2. PubMed ID: 7898250
    [No Abstract]   [Full Text] [Related]  

  • 25. A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients.
    Wientjens DP; Rikken B; Wit JM; Hofman A; Stricker BH
    Neuroepidemiology; 2000; 19(4):201-5. PubMed ID: 10859499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probable Creutzfeldt-Jakob disease after a cadaveric dural graft.
    Lang CJ; Schüler P; Engelhardt A; Spring A; Brown P
    Eur J Epidemiol; 1995 Feb; 11(1):79-81. PubMed ID: 7489777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with extractive growth hormone and Creutzfeld-Jakob encephalopathy: a new iatrogenic tragedy].
    Battin J
    Pediatrie; 1993; 48(2):91-5. PubMed ID: 8393184
    [No Abstract]   [Full Text] [Related]  

  • 28. Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France.
    Peckeu L; Brandel JP; Welaratne A; Costagliola D; Haïk S
    Neurology; 2018 Aug; 91(8):e724-e731. PubMed ID: 30045957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prion diseases. Review of the literature on the light of two case reports of Creutzfeldt-Jakob disease].
    Skjaerpe KA; Tysnes OB; Mørk S
    Tidsskr Nor Laegeforen; 1996 Mar; 116(9):1081-5. PubMed ID: 8658476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.
    Mitrova E; Belay G
    Bratisl Lek Listy; 1999 Apr; 100(4):187-91. PubMed ID: 10914140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation.
    Uttley L; Carroll C; Wong R; Hilton DA; Stevenson M
    Lancet Infect Dis; 2020 Jan; 20(1):e2-e10. PubMed ID: 31876504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

  • 33. Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.
    Cordery RJ; Hall M; Cipolotti L; Al-Sarraj S; O'Donovan DG; Davidson L; Adlard P; Rossor MN
    J Neurol Neurosurg Psychiatry; 2003 Oct; 74(10):1412-6. PubMed ID: 14570836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iatrogenic Creutzfeldt-Jakob disease.
    Rappaport EB
    Neurology; 1987 Sep; 37(9):1520-2. PubMed ID: 3306455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?
    Boyd A; Klug GM; Schonberger LB; McGlade A; Brandel JP; Masters CL; Collins SJ
    Med J Aust; 2010 Sep; 193(6):366-9. PubMed ID: 20854243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease: search for a genetic susceptibility by analysis of the PRNP coding region.
    Jaegly A; Boussin F; Deslys JP; Dormont D
    Genomics; 1995 May; 27(2):382-3. PubMed ID: 7558015
    [No Abstract]   [Full Text] [Related]  

  • 37. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autopsies reveal signs of Alzheimer's in growth-hormone patients.
    Abbott A
    Nature; 2015 Sep; 525(7568):165-6. PubMed ID: 26354460
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone].
    Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062
    [No Abstract]   [Full Text] [Related]  

  • 40. Iatrogenic Creutzfeldt-Jakob disease.
    Kobayashi A; Kitamoto T; Mizusawa H
    Handb Clin Neurol; 2018; 153():207-218. PubMed ID: 29887137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.